Dr Stuart Onions has over 14 years drug discovery experience. Having gained experience at a drug discovery CRO, he has benefitted from a broad range of approaches and tactics to deliver optimal preclinical candidates. He has a profound flair of servicing, influencing and guiding biotechnology companies though the discovery process. He has previously led multiple medicinal chemistry programs delivering five compounds to ongoing clinical trials. More recently, two first-in-class preclinical oncolytic therapeutic agents have been discovered under his supervision. He is recognised as an inventor on over thirty patents and authored eleven papers. Stuart holds a first class chemistry degree and Ph.D. in supra-molecular chemistry.
Stuart is Director of Research Management at Sygnature Discovery, an integrated drug discovery CRO, and he also serves as a non-executive Director of Peak Proteins, a CRO specialising the production, supply and crystallisation of proteins.